Author: therawinformant

  • 3 ASX 200 shares to buy and hold for a decade

    hand holding hourglass with floating dollar signs, long term investing

    The potential of super-sized profits is very attractive for most people, which can lead to trading in the latest fad. However, one of the wealthiest people in the world, Warren Buffett, favours a different approach for building wealth on the share market – buying quality companies at attractive prices and holding for decades.

    To use a Buffett-esque investing strategy, I think an investment in ASX 200 shares such as Wesfarmers Ltd (ASX: WES), Goodman Group (ASX: GMG) and Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) could deliver investors with solid returns over the long term.

    Wesfarmers 

    Wesfarmers has continued to perform strongly amid the coronavirus pandemic, largely because of its popular Bunnings Warehouse and Officeworks chains. According to a recent update released on 9 June, Bunnings reported a surge in sales in in 2H20 (to date) of 19.2% and Officeworks saw sales grow by 27.8% for the same period. In addition, Catch.com.au, Wesfarmers’ online marketplace, achieved strong sales growth of 68.7% for 2H20.

    The increased demand during coronavirus restrictions is due to people spending more time with DIY projects, studying, working and general shopping from home. Fortunately, Wesfarmers appeared to hold the right businesses at the right time. However, the laggard in performance has been Target, with the company recently announcing the overhaul of its Target stores.

    Due to the size of the business, its dominant position in the retail marketplace, I believe assigning Wesfarmers shares a spot in your portfolio could be rewarding over a decade.

    Goodman Group

    In a newsletter presented to investors on 11 June 2020, Goodman presented insights about the business, reaffirming that it remains in a solid position despite COVID-19 disruptions. The group’s performance is supported by the demand for its infrastructure, which has accelerated because of the rise of online shopping amid the pandemic.

    In addition, for the 9 months to 31 March 2020, the group reported occupancy rates of 97.5%, which highlights limited disruption in its warehouse facilities. Furthermore, Goodman Group’s $4.8 billion in development work in progress demonstrates the demand for its properties. Future growth in development is expected.

    The group is a major beneficiary of the increase in online shopping. By providing online retailers like Amazon with warehouses for stock, I believe Goodman Group should continue to see a lift in demand for its services over the long term.

    Fisher & Paykel Healthcare 

    Late last month, Fisher & Paykel delivered its preliminary final report to the ASX. In this announcement, the group revealed an increase in operating revenue of 18% to $1.26 billion. Additionally, it reported net profit after tax up 37% to $287.3 million.

    While Fisher & Paykel has been a key beneficiary to the uplift in demand for healthcare products as a result of the coronavirus pandemic, it has also delivered increases in its earnings over the long term. Looking forward, I see the share benefitting from this continued demand for healthcare products because of an ageing population.

    Foolish takeaway

    Before buying shares, to analyse whether a share could represent a good long-term investment it’s a good idea to ask whether you believe the company will still be thriving in a decade’s time and try to anticipate if there will still be demand for its products or services. 

    Take the 3 ASX 200 shares above, for example. People could continue to shop at Wesfarmers for their everyday items either in store and online. In addition, a greater number of the population could be shopping online, requiring more of Goodman’s warehouses. Lastly, the rise in an ageing population could see continued demand for healthcare products produced by Fisher & Paykel. 

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Motley Fool contributor Matthew Donald owns shares of Wesfarmers Limited. The Motley Fool Australia owns shares of Wesfarmers Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 ASX 200 shares to buy and hold for a decade appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3fvWhpk

  • Afterpay share price shoots higher on Apple Pay and Google Pay updates

    Payment Technology

    The Afterpay Ltd (ASX: APT) share price is rebounding strongly from yesterday’s weakness.

    In morning trade the payments company’s shares are up 3% to $68.60.

    Why is the Afterpay share price rebounding today?

    Today’s gain appears to be in response to a couple of announcements the company made in respect to its U.S. operations this morning.

    According to the first announcement, the company’s millions of U.S. customers can now use Apple Pay to make purchases through its buy now pay later platform in physical retail stores and online.

    Beginning this month, select retail stores in the U.S. such as Forever21, Fresh, Skechers, and Solstice Sunglasses will begin offering Afterpay via Apple Pay.

    This has the potential to be a key driver of growth for its U.S. business in the future. As of the end of the 2019 calendar year, Afterpay’s in-store offering represented approximately 24% of total ANZ underlying sales.

    Co-founder and CEO, Nick Molnar, commented: “As we enter the second half of the year and retail re-emerges across the world, it’s critical we help our partners drive business growth, both online and offline.”

    “As a proven solution for driving incremental sales and new customer growth, we are thrilled to introduce our new omni-channel solution to U.S retailers as they begin to open their doors and bring shoppers back to their physical stores,” he added.

    What else did Afterpay announce?

    In an accompanying announcement, Afterpay revealed that it won’t be neglecting Android phone users.

    The company has also signed an agreement in the U.S. with Google Pay to offer its buy now pay later service to Android users.

    Mr Molnar commented: “Afterpay and Google Pay give shoppers the ability to choose either physical or online shopping while still being able to budget their own money and avoid expensive loans, interest and fees – which has shown to attract new customers and drive more sales conversion for our retail partners. We are thrilled to partner with Google to make shopping and paying in-store convenient, secure and contactless.”

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    The post Afterpay share price shoots higher on Apple Pay and Google Pay updates appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/30eOO81

  • 2 tech ETFs to buy for strong returns

    Exchange Traded Fund (ETF)

    Technology exchange-traded funds (ETFs) could be the best ETFs to buy right now.

    During the first set of global COVID-19 lockdowns it was technology businesses that really shone through.

    Most tech shares are able to deliver their service digitally to customers/clients. This means their revenue and profit is less likely to be affected.

    Indeed, there were some tech businesses that have seen an increase in demand because of COVID-19 impacts. For example, on the local market, Nextdc Ltd (ASX: NXT) is seeing more demand for its data centre services. Internationally we’ve seen shares like Microsoft report a huge increase in demand as people shifted to cloud computing services. 

    If there is another market selloff due to COVID-19 restrictions then tech shares could outperform again. Tech share earnings as a whole are likely to be affected less (again) and therefore the tech share prices may not fall as much as the broader market.

    BetaShares S&P/ASX Australian Technology ETF (ASX: ATEC)

    The ASX index is dominated by the big players in the ASX 20 like CSL Limited (ASX: CSL), Commonwealth Bank of Australia (ASX: CBA), BHP Group Ltd (ASX: BHP) and Wesfarmers Ltd (ASX: WES).

    But many of the big ASX companies, like the banks and resource giants, are now mature businesses and offer little growth potential.

    It’s particularly the ASX tech shares that are generating the biggest revenue and profit growth in percentage terms compared to other industries.

    This ETF gives you exposure to many of the ASX’s leading technology shares. Some of its largest holdings are: Afterpay Ltd (ASX: APT), Xero Ltd (ASX: XRO), Seek Limited (ASX: SEK), Nextdc, REA Group Limited (ASX: REA) Carsales.com Ltd (ASX: CAR), Altium Limited (ASX: ALU), Appen Ltd (ASX: APX) and WiseTech Global Ltd (ASX: WTC).

    You have to have a somewhat positive view about Afterpay if you invest in this ETF because at the moment it makes up 18% of the total ETF.

    With this ETF you also get exposure to some of the smaller, but compelling, ASX tech shares as well like EML Payments Ltd (ASX: EML), Kogan.com Ltd (ASX: KGN), Bravura Solutions Ltd (ASX: BVS), Pro Medicus Ltd (ASX: PME) and Tyro Payments Ltd (ASX: TYR).

    The ETF has been a strong performer in its very limited history. It was launched on 4 March 2020. Over the three months to 30 June 2020, the ETF produced a net return of 47% as the share market recovered.

    Its annual management fee is 0.48% per annum.

    BetaShares NASDAQ 100 ETF (ASX: NDQ)

    Many of the technology shares listed in the US are a lot bigger than the ones in Australia. Those tech businesses are financial juggernauts with powerful market positions.

    I think everyone should have some sort of exposure to the FAANG shares. I believe they’re likely to produce strong growth for years to come. Plus, their earnings come from all across the world from multiple divisions. 

    Currently, the ETF’s biggest positions are: Apple, Microsoft, Amazon, Facebook, Alphabet, Tesla, Intel, Nvidia and Netflix.

    These businesses have proven to be resilient during the difficult COVID-19 circumstances and long-term investors have done very well holding them. Since inception in May 2015, this ETF has returned an average of 20.75% per annum.

    Past performance is certainly no guarantee of future performance, but this ETF has consistently performed strongly for investors. Those big tech businesses keep delivering good revenue growth year after year.

    Microsoft, Amazon and Alphabet are key for the world’s shift to cloud computing. Alphabet and Facebook are capturing a lot of the increasing digital advertising expenditure. Amazon is seeing enormous retail growth because of the COVID-19 impacts on physical retail stores. Netflix was a source of entertainment for many people who were locked down in their houses.

    This ETF has an annual management fee of just 0.48%.

    Foolish takeaway

    I really like both of these ETFs, though the Australian one is probably a bit too focused on Afterpay at the moment for effective diversification for my liking. At the current prices I’d probably go for the NASDAQ ETF because of how strong the economic moats and balance sheets are.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Tristan Harrison owns shares of Altium. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Altium, BETANASDAQ ETF UNITS, CSL Ltd., Kogan.com ltd, Tyro Payments, and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Bravura Solutions Ltd, Emerchants Limited, and Pro Medicus Ltd. The Motley Fool Australia owns shares of AFTERPAY T FPO, Appen Ltd, Wesfarmers Limited, and WiseTech Global. The Motley Fool Australia has recommended BETANASDAQ ETF UNITS, carsales.com Limited, Kogan.com ltd, REA Group Limited, and SEEK Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 2 tech ETFs to buy for strong returns appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/393CbAv

  • Is Altium still a leading ASX 200 tech share to buy?

    illuminated circuit board

    When it comes to growth, the Altium Limited (ASX: ALU) share price has fallen behind many of its ASX 200 tech share cohorts. These include the likes of Afterpay Ltd (ASX: APT), Xero Limited (ASX: XRO) and Appen Ltd (ASX: APX) which have all seen considerable growth year to date. Meanwhile, the Altium share price has languished in 2020. Has Altium fallen from grace or is it still a leading ASX 200 tech share to buy? 

    Revenue growth but below consensus 

    On 22 June, Altium advised that its run-rate has fallen behind current analyst consensus despite reasonable subscriber and revenue growth. It cites the new lockdowns in China and an increase in COVID-19 cases in parts of the United States as having some impact on the company’s final sprint to the close of fiscal 2020. Altium has been aggressively closing sales at a significant discount. The Altium website showed that its printed circuit board design platform was discounted from AUD$10,445 to $7,185 or 12 monthly instalments of $599. 

    On 14 July, Altium announced that it had achieved 10% revenue growth and exceeded its 50,000 subscriber target. The significant product discounting is taking a toll on its revenue despite record subscribers, the roll-out of its new cloud platform (Altium 365) and launch of its digital sales stream. 

    COVID-19 challenges persist 

    Altium pointed to Beijing’s recent lockdown and soaring COVID-19 cases in the US as challenges to its growth story. These challenges continue to persist with the US recording its largest increase in new cases last weekend. The company’s main revenue generating service is from its Boards and Systems segment which sells its flagship Altium Designer tool. From a revenue perspective, its 1H20 major revenue generating regions for Boards and Systems were America with 40%, EMEA (Europe, the Middle East and Africa) with 34% and China with 15%. All three regions continue to face challenges with containing COVID-19 which will likely be a drag on revenues beyond the short term. 

    Foolish takeaway 

    I believe Altium’s decision to aggressively discount its product offering and close deals is not a solution to the challenges it faces as a result of COVID-19. The selling more for less approach is not sustainable, especially if the economic impact of COVID-19 persists for the medium term. With the persistent challenges that Altium faces, I believe investors may be better off looking at other ASX 200 tech shares such as Xero and Appen. 

    3 “Double Down” Stocks To Ride The Bull Market

    Motley Fool resident tech stock expert Dr. Anirban Mahanti has stumbled upon three under-the-radar stock picks he believes could be some of the greatest discoveries of his investing career.

    He’s so confident in their future prospects that he has issued “double down” buy alerts on each of these three stocks to members of his Motley Fool Extreme Opportunities stock picking service.

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Lina Lim has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Altium and Xero. The Motley Fool Australia owns shares of AFTERPAY T FPO and Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Is Altium still a leading ASX 200 tech share to buy? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2DChbFi

  • Is the BHP share price about to surge?

    Price up or down

    The BHP Group Ltd (ASX: BHP) share price is down 4.8%, year to date, but I think it’s well-placed to climb higher in 2020.

    Why the BHP share price could be set to surge

    I think there are a couple of things to consider for BHP. One is the strong demand drivers that I’m seeing in the economy right now.

    The coronavirus pandemic has stunted global economic growth and spooked investors. However, governments will be looking to stimulate their economies with whatever they can, and one obvious candidate is infrastructure. That’s good news for BHP as a major global supplier of iron ore.

    There’s also the relative value argument. The BHP share price has fallen 4.8% but is still outperforming the S&P/ASX 200 Index (ASX: XJO). However, fellow iron ore miner Fortescue Metals Group Limited (ASX: FMG) has seen its shares rocket 43.9% higher this year.

    It’s true that Fortescue trades at a lower price to earnings (P/E) ratio than BHP. However, if we continue to see strong demand, I think the BHP share price could benefit from rising iron ore prices and the momentum factor.

    Why is infrastructure good for BHP?

    Infrastructure is a good fiscal stimulator given the size, value and timeline of these projects. Major roadworks, buildings, railworks projects and the like can go for years. That means plenty of money to flow through to contractors and employees, as well as downstream suppliers. 

    The resource-intensive nature also makes any infrastructure boom good news for the BHP share price. More infrastructure means more demand for steel, driving up iron ore demand and therefore prices.

    Does that mean BHP is in the buy zone?

    I think a strong blue-chip like BHP is often quite a good option for portfolios, however, the Resources sector is notoriously volatile and ultimately dependent on global commodity prices.

    The BHP share price is still down in 2020, while Fortescue shares are rocketing higher and the ASX 200 looks to be moving sideways right now.

    I think as governments start to plot a path towards economic recovery, we could see the BHP share price start to climb. That’s particularly the case if we see a decent earnings result from the Aussie miner on 18 August.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Is the BHP share price about to surge? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2Zu6NYU

  • Coupa Software Shows Strength

    Coupa Software Shows StrengthCoupa Software (COUP, daily) found short-term support at its 21-day line.

    from Yahoo Finance https://ift.tt/32jEC0k

  • Biggest dividend cuts in 10 years to hit ASX investors next month

    man with hands on head looking at chart with red downward arrow, stock market crash

    Income investors should brace themselves for the worst dividend hit since the GFC when ASX companies present their profit results next month.

    You can blame this on the COVID-19 meltdown with Bloomberg estimating that stocks on the S&P/ASX 200 Index (Index:^AXJO) could crash by up to 40% in 2020 and a further 11% in 2021.

    The August reporting season is the first time ASX stocks will have to put their cards on the table since the coronavirus pandemic triggered a shutdown of the global economy.

    ASX banks dividend disaster

    We’ve already gotten a small taste of what’s to come with three of the big banks slashing or suspending dividends two months ago.

    This explains a big part of why the Westpac Banking Corp (ASX: WBC) share price and Australia and New Zealand Banking GrpLtd (ASX: ANZ) share price are underperforming. They both held back from paying any dividend, while the National Australia Bank Ltd. (ASX: NAB) share price is under pressure from a cap raise and a 60% plus cut to its interim dividend.

    Their financial year end is different from most other companies.

    Risk of CBA suspending dividend is growing

    I have written about how Commonwealth Bank of Australia (ASX: CBA) may have dodged a bullet as it releases its full year results next month. My initial thoughts were that the worst of the COVID-19 impact would be behind us and that management didn’t have to be as conservative on dividends as its peers.

    But I wasn’t counting on a dreaded resurgence in coronavirus infections. Large parts of Victoria have gone back into a stage three lockdown and conditions seem to be worsening.

    There’s talk that the state will have to go into a stricter stage four lockdown, while New South Wales may be next to shutdown vast parts of its economy if the spike in cases can’t be controlled soon.

    Given the heightened level of uncertainty, it’s reasonable to think that CBA might suspend its dividend till later this calendar year. If our biggest home lender does this, it won’t be due to the lack of cash as its balance sheet can fund a decent payout. It will be because of fear.

    Why many ASX stocks will be tempted to cut dividends

    Other ASX stocks will be quick to leverage on this climate of anxiety too. The risk-reward for cutting dividends is too attractive for management teams to ignore.

    In the first instance, boards won’t be flogged for committing the cardinal sin of dividend cuts during a global crisis. It’s almost like a “hall pass”.

    On the flipside, if they don’t cut dividends to shore up their cash position, and they run unexpectedly run thin on capital later, they will be punished severely then.

    Further, extra cash on the balance sheet will give ASX companies greater flexibility to boost their share prices later. This can be trough capital returns, business expansion or acquisitions.

    On that last point, the COVID-19 turmoil is bound to throw up some opportunistic targets as several industries will likely be forced to consolidate.

    Other ASX stocks at risk of dividend disappointment

    Another sector that’s at risk of slicing or suspending their dividends in August is property. Retail and office landlords like Vicinity Centres (ASX: VCX) and Stockland Corporation Ltd (ASX: SGP) are doing it tough.

    Any stock related to travel like Flight Centre Travel Group Ltd (ASX: FLT) and Sydney Airport Holdings Pty Ltd (ASX: SYD) will also be under pressure to keep as much capital on their balance sheets as they can. The recovery in international travel looks to be a long way off.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Brendon Lau owns shares of Australia & New Zealand Banking Group Limited, Commonwealth Bank of Australia, National Australia Bank Limited, and Westpac Banking. Connect with me on Twitter @brenlau.

    The Motley Fool Australia has recommended Flight Centre Travel Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Biggest dividend cuts in 10 years to hit ASX investors next month appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3j6rW2Q

  • Analyst Predicts Approval for Moderna’s COVID-19 Vaccine

    Analyst Predicts Approval for Moderna’s COVID-19 VaccineShares of the vaccine maker Moderna (MRNA) are up by double digits in after-hours session Tuesday, thanks to a positive clinical update for its experimental coronavirus vaccine mRNA-1273. "Phase 1 data demonstrate that vaccination with mRNA-1273 elicits a robust immune response across all dose levels and clearly support the choice of 100 µg in a prime and boost regimen as the optimal dose for the Phase 3 study,” said Tal Zaks, Chief Medical Officer of Moderna.Following Moderna’s massive gains so far this year, 333% to be exact, is now the right time to recommend investors snap up shares? Jefferies analyst Michael Yee has an almost Schwarzenegger-ish answer to such a question: “We take a stand: If it works, stock will be going up.”To this end, Yee initiated coverage on MRNA with a Buy rating. However, his $90 price target implies a modest 5% upside from current levels. (To watch Yee’s track record, click here)Unsurprisingly, the bulk of Yee’s bullish assessment is reserved for the company's COVID-19 vaccine candidate.Expanding on this blunt assessment, Yee said, “We believe the Street will be surprised to the upside if the COVID-19 vaccine works, gets approved by early 2021, and there are multi-billion dollars of purchase orders from USA and around the world. The Street is divided as to what will happen or if the vaccine will even work and is hugely divided on valuation. We believe the vaccine will get approved and could do $5B+ in orders over the next few years and the stock will head higher.”Yee’s confidence is partly based on talks with KOLs (key opinion leaders) who have prompted a belief there is “a good probability the vaccine will work,” and should at minimum be granted Emergency approval by early next year.Moderna has emerged as one of the frontrunners in the race to bring a viable vaccine to market, but there’s a while to go yet before breaking out the champagne. mRNA-1273 is currently in a phase 2 trial, with data expected in the fall, while a phase 3 study is expected to launch this month. It goes without saying, positive results from the trials could act as additional catalysts for further share appreciation.The Jefferies analyst is not alone in his positive assessment. Based on 14 Buy ratings and 2 Holds, Moderna has a Strong Buy consensus rating. With an average price target of $86.46, the analysts expect a 15% premium to be added to the share price over the next 12 months. (See Moderna stock analysis on TipRanks)To find good ideas for healthcare stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

    from Yahoo Finance https://ift.tt/309bdU5

  • Buy these ASX shares today and pay no CGT when you sell

    asx 200 shares

    Believe it or not, there are a handful of shares that you can still buy today on the ASX that are exempt from tax when you finally sell them. I’m talking about ASX-listed pooled development fund (PDF) companies, which, despite their attractiveness, still tend to fly under the radar of most investors.

    First, the history lesson: the PDF program was launched by the Paul Keating government in 1992 to help increase the supply of capital to small and medium-sized (SMEs) enterprises, based on certain criteria. A PDF raises capital and makes equity investments in SMEs and under the program, pooled development funds were offered generous tax concessions. While the PDF program has been closed to new registrations since 2007, existing registered funds continue to operate, and as such continue to have PDF status for tax purposes.

    What are the tax breaks?

    Buy one or more of these ASX PDF shares, and you’ll receive a double-whammy in tax benefits.

    Firstly, companies with PDF status are taxed at 15% on their income and capital gains received from their investments. By comparison, the full company tax rate sits at 30% and the lower company tax rate is 27.5%.

    Secondly (and more importantly), as a shareholder in an ASX-listed PDF, you’re exempt from the capital gains tax after selling. Assuming you’re an Australian resident, you’ll also receive franked and unfranked dividends that are also exempt from tax. There’s also the option to use the imputation credits attached to the franked dividends to offset other tax obligations.

    However, the benefit doesn’t come without a potential downside, which is that you’re not entitled to deductions or capital loss on the sale of these shares.

    PDFs trading on the ASX

    If you like the idea of investing in Australian SMEs, while also locking in some future tax breaks, here’s a closer look at the 6 PDF shares trading on the ASX.

    Authorised Investment Fund (ASX: AIY)

    AIY invests in innovative SMEs within high-growth industries that capture the multiples of future consumer spending. For example, it has a 30% stake in Aenea Cosmetics, which offers customers a full range of epigenetic skin care products, and a 30% stake in global media representation company Asian Integrated Media.

    AIY also owns a stake in NSX-listed company, Endless Solar, which has exposure to the renewable energy market.

    While the company is currently suspended from trading pending its responses to an ASX enquiry, at 3 cents per share the last trade is undervalued relative to Morningstar’s fair valuation of 4 cents.

    MEC Resources (ASX: MMR) 

    This exploration company offers investors the opportunity to secure equity in companies exploring for large energy and mineral discoveries like oil, uranium, nickel, iron ore and gold. Its primary focus is on companies with the potential to yield significant returns by advancing their discoveries into production.

    The company has called for a voluntary suspension of trading until 17 July pending a meeting of shareholders to effect an in-specie distribution of the Advent Energy shares that it holds. At 0.4 cents the stock is currently trading a discount to Morningstar’s fair value of 1 cent per share.

    Strategic Elements Ltd (ASX: SOR)

    Strategic Elements is advancing its in-house developed ‘printable nanocube memory ink’, which hopes to revolutionise the ability to print onto multiple surfaces, while remaining flexible and transparent. Its chosen tech field targets the global multi-billion dollar printed electronics market for use in advanced computing applications and improving data storage capabilities.

    The company is also working with the University of New South Wales and has attracted 2 other significant development partners – CSIRO and VTT Finland – both world leaders in their prospective fields. Strategic Elements is also involved in a collaborative working group called PrintoCent, which includes large global companies in printed electronics, such as Nokia, Merck and BASF.

    Its subsidiary Stealth Technologies is developing technologies to help vehicles to drive autonomously, and do physical tasks with robotics.

    BTC Health Ltd (ASX: BTC)

    This Australian specialty biopharmaceutical company provides partnering, product development and commercialisation capabilities to partners across the Asia-Pacific. It’s dedicated to assisting these partners through the final stages of product development, regulatory submissions, reimbursement, distribution and post-marketing compliance and is actively seeking new investment opportunities in the biotechnology life-science sectors.

    Demand for BTC’s specialty health products reduced significantly following the cancellation of category two and three elective surgeries by the Australian Government on 25 March. As a result, the share price was heavily sold-off in February, and at 9.5 cents per share, it remains significantly undervalued relative to Morningstar’s fair value of 13 cents.

    I expect the full resumption of elective surgery to be reflected in the share price – sooner or later.

    Generation Development Group Ltd (ASX: GDG)

    Formerly known as Austock Group, Generation Development Group is a specialist provider of investment bond product solutions. The group established Australia’s first flexible investment bond product over 15 years ago.  

    Generation Development Group also operates Austock Financial Services, which provides administrative services, including unit pricing, fund valuation, investment and fund accounting, fund administration and business registry services.

    The stock currently trades for 76 cents, slightly higher than Morningstar’s fair valuation of 66 cents.

    Acrux Limited (ASX: ACR)

    Acrux listed in 2004 as a biotech share dedicated to developing and commercialising topical pharmaceuticals. Its early claim to fame was as the provider of roll-on testosterone, but its fortunes deteriorated when the US Food and Drug Administration (FDA) linked testosterone drugs to heart failure and strokes.

    Since then, Acrux has focused on developing a pipeline of 10 topical generic drugs, and currently has 3 pharmaceutical products approved and marketed. The Acrux share price surged by as much as 62.96% in late May 2020, following revelations it has entered into an exclusive sales, marketing and distribution agreement with US-based private company TruPharma.

    What I think is appealing is TruPharma’s proven track-record of building niche product portfolios and getting difficult products FDA-approved and into the market. Subject to approval by the FDA, TruPharma will be responsible for the commercialisation of 6 existing products from the Acrux pipeline.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Mark Story has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Buy these ASX shares today and pay no CGT when you sell appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2DCdMq0

  • Servicenow Cutdown

    Servicenow CutdownServiceNow (NOW, daily) bounced off its 50-day moving average.

    from Yahoo Finance https://ift.tt/2OnyonZ